Sandra Silberman
Chief Tech/Sci/R&D Officer chez MOLECULIN BIOTECH, INC.
Fortune : 94 $ au 31/03/2024
Profil
Sandra Leta Silberman is currently the Chief Medical Officer for Moleculin Biotech, Inc. and CNS Pharmaceuticals, Inc. She previously worked as the Senior Director of Clinical Research at Novartis Corp., Chief Medical Officer at Scorpius Holdings, Inc., and Vice President at Eisai Medical Research, Inc. Silberman holds a doctorate degree from Weill Cornell Medical College and The Johns Hopkins University School of Medicine, and an undergraduate degree from Zanvyl Krieger School of Arts & Sciences.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/07/2023 | 261 ( 0,00% ) | 94 $ | 31/03/2024 |
Postes actifs de Sandra Silberman
| Sociétés | Poste | Début |
|---|---|---|
| MOLECULIN BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 08/11/2017 |
| CNS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2017 |
Anciens postes connus de Sandra Silberman
| Sociétés | Poste | Fin |
|---|---|---|
| Eisai Medical Research, Inc. | Corporate Officer/Principal | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | - |
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Sandra Silberman
| Weill Cornell Medical College | Doctorate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
| Zanvyl Krieger School of Arts & Sciences | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SCORPIUS HOLDINGS, INC. | Health Technology |
| MOLECULIN BIOTECH, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
| Eisai Medical Research, Inc. | |
| CNS Pharmaceuticals, Inc. |
